Extranodal NK-T-cell lymphoma epidemiology and demographics

	Extranodal NK-T-cell lymphoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Extranodal NK-T-cell lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Staging
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Xray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Extranodal NK-T-cell lymphoma epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Extranodal NK-T-cell lymphoma epidemiology and demographics
CDC on Extranodal NK-T-cell lymphoma epidemiology and demographics
Extranodal NK-T-cell lymphoma epidemiology and demographics in the news
Blogs on Extranodal NK-T-cell lymphoma epidemiology and demographics
Risk calculators and risk factors for Extranodal NK-T-cell lymphoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD [2] Sowminya Arikapudi, M.B,B.S. [3]

Overview

Natural Killer (NK) cell lymphoma is a rare disease. NK/T cell lymphoma, nasal type (NKTCL) and aggressive NK-cell leukemia (ANKCL) have a higher incidence in Asia, Central, and South America.
Nk cell lymphoma is usually associated with Epstein-Barr virus infection.

NK cell lymphoma shows a poor prognosis because of rapid local progression and distant metastasis.^[1]